Dräger Targets 2030 EBIT Margin of 10%-12%
- Dräger targets net sales of around EUR 4.5 billion by 2030, up from EUR 3.5 billion in 2025.
- The EBIT margin is forecast to reach 10%–12%, compared with 6.7% in 2025.
- Medical division targets include around EUR 2.5 billion in net sales, with an EBIT margin of 7%–9%.
- The safety division aims for around EUR 2 billion in net sales, with an EBIT margin of 14%–16%.
- Dividend distributions will remain at least 30% of net profit, implying double-digit dividend growth in coming years.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drägerwerk AG & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2436204_en) on November 18, 2026, and is solely responsible for the information contained therein.